An engineered four-stranded coiled coil substitutes for the tetramerization domain of wild-type p53 and alleviates transdominant inhibition by tumor-derived p53 mutants

Cancer Research

Volumn 56, Issue 1, 1996, Pages 158-163

  Waterman, Matthew J F ^a   Waterman, Jennifer L F ^a   Halazonetis, Thanos D ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE ZIPPER PROTEIN; MUTANT PROTEIN; PROTEIN P53; TUMOR PROTEIN;

ARTICLE; CONTROLLED STUDY; GENE THERAPY; GENETIC ENGINEERING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN POLYMERIZATION; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; DNA, RECOMBINANT; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN CONFORMATION; RECOMBINANT FUSION PROTEINS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030052598     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Maltzman, W , and Czyzyk, L. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol., 4 1689-1694, 1984
2. Kastan, M. B., Onyekwere, O , Sidransky, D., Vogelstein, B., and Craig, R W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res , 51 6304-6311, 1991.
3. Lowe, S. W. Ruley, H. E., Jacks, T., and Housman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993.
4. Lowe, S. W , Schmitt, E M., Smith, S. W., Osborne, B. A , and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes Nature (Lond.), 362 847-849, 1993.
5. Clarke, A. R , Purdie, C. A., Harrison, D J , Morris, R. G., Bird, C. C., Hooper, M. L., and Wyllie, A H Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (Lond.), 362: 849-852, 1993.
6. 1 arrest and long-term induction of Cip1 in normal human fibroblasts Genes & Dev., 8: 2540-2551, 1994.
7. Fields, S., and Jang, S K. Presence of a potent transcription activating sequence in the p53 protein Science (Washington DC), 249. 1046-1049, 1990.
8. Unger, T., Nau, M. N , Segal, S., and Minna, J. D p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer EMBO J , 11: 1383-1390, 1992.
9. Milner, J., Medcalf, E. A., and Cook, A. C Tumor suppressor p53 analysis of wild-type and mutant p53 complexes. Mol. Cell Biol , 11: 12-19, 1991
10. Sturzbecher, H. W , Brain, R., Addison, C., Rudge, K., Remm, M., Grimaldi, M , Keenin, E., and Jenkins, J. R. A C-terminal α-helix plus basic region motif is the major structural determinant of p53 tetramerization. Oncogene, 7. 1513-1523, 1992.
11. Sakamoto, H., Lewis, M S , Kodama, H , Appella, E , and Sakaguchi, K. Specific sequences from the carboxyl terminus of human p53 gene product form anti-parallel tetramers in solution. Proc. Natl. Acad Sci. USA. 91: 8974-8978, 1994.
12. Wang, P., Reed, M., Wang, Y., Mayr, G , Stenger, J. E., Anderson, M E., Schwedes, J F., and Tegtmeyer, P. p53 domains: structure, oligomerization and transformation. Mol. Cell Biol., 14: 5182-5191, 1994.
13. Bargonetti, J., Manfredi, J. J., Chen, X., Marshak, D. R., and Prives, C. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein. Genes & Dev., 7. 2565-2574, 1993.
14. Pavletich, N P., Chambers, K. A., and Pabo, C. O The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. Genes & Dev., 7: 2556-2564, 1993
15. Wang, Y., Reed, M., Wang, P., Stenger, J. E., Mayr, G., Anderson, M. E., Schwedes, J F., and Tegtmeyer, P. p53 domains: identification and characterization of two autonomous DNA-binding regions. Genes & Dev., 7: 2575-2586, 1993.
16. Halazonetis, T. D., and Kandil, A. N Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants EMBO J., 12: 5057-5064, 1993.
17. Harris, C. C. p53: at the crossroads of molecular carcinogenesis and risk assessment. Science (Washington DC), 262: 1980-1981, 1993
18. Friend, S p53: a glimpse at the puppet behind the shadow play. Science (Washington DC), 265: 334-335, 1994.
19. Bargonetti, J., Friedman, P. N., Kern, S. E , Vogelstein, B., and Prives, C. Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication. Cell. 65: 1083-1091, 1991.
20. Kern, S. E , Kinzler, K W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C., and Vogelstein, B. Identification of p53 as a sequence-specific DNA-binding protein. Science (Washington DC), 252: 1708-1711, 1991.
21. Diller, L., Kassel, J., Nelson, C. E., Gryka, M. A., Litwak, G., Gebhardt, M , Bressac, B , Ozturk, M., Baker, S I, Vogelstein, B., and Friend, S. H. p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell. Biol , 10: 5772-5781, 1990.
22. Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. V., and Vogelstein, B Suppression of human colorectal carcinoma cell growth by wild-type p53. Science (Washington DC), 249: 912-915, 1990.
23. Eliyahu, D., Michalovitz, D., Eliyahu, S., Pinhasi-Kimhi, O., and Oren, M. Wild-type p53 can inhibit oncogene-mediated focus formation. Proc. Natl. Acad. Sci. USA, 86: 8763-8767, 1989.
24. Mercer, W. E., Shields, M. T., Amin, M., Sauve, G J., Appella, E., Romano, J. W., and Ullrich, S. J Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53 Proc. Natl. Acad. Sci. USA, 87: 6166-6170, 1990.
25. Finlay, C. A., Hinds, P W., and Levine, A. J The p53 proto-oncogene can act as a suppressor of transformation. Cell, 57. 1083-1093, 1989
26. Martinez, J., Georgoff, I., Martinez, J., and Levine, A. J. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes & Dev., 5: 151-159, 1991.
27. Bargonetti, J., Reynisdóttir, I., Friedman, P. N., and Prives, C. Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. Genes & Dev., 6. 1886-1898, 1992.
28. Kern, S E , Pietenpol, J A., Thiagalingam, S., Seymour, A., Kinzler, K. W., and Voselstein, B. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science (Washington DC), 256: 827-830, 1992.
29. Milner, J., and Medcalf, E. A Cotranslation of activated mutant p53 with wild-type drives the wild-type p53 protein into the mutant conformation. Cell, 65: 765-774, 1991.
30. Ehyahu, D., Raz, A., Gruss, P., Givol, D., and Oren, M. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells Nature (Lond), 312: 646-649, 1984.
31. Parada, L. F., Land, H , Weinberg, R. A., Wolf, D., and Rotter, V. Cooperation between gene encoding p53 tumor antigen and ras in cellular transformation Nature (Lond), 312: 649-651, 1984.
32. Jenkins, J. R., Rudge, K., and Currie,G. A. Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53. Nature (Lond), 312. 651-654, 1984.
33. Unger, T , Mietz, J. A., Scheffner, M., Yee, C. L. and Howley, P. M. Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression. Mol. Cell Biol., 13: 5186-5194, 1993
34. Shaulian, E., Zauberman, A., Ginsberg, D., and Oren, M. Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol. Cell Biol., 12: 5581-5592, 1992.
35. Reed, M., Wang, Y., Mayr, G., Anderson, M. E., Schwedes, J. F , and Tegtmeyer, P. p53 domains, suppression, transformation and transactivation. Gene Expression, 3: 95-107, 1993.
36. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A., and Oren, M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (Lond.), 352. 345-347, 1991
37. Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, B., and Costa, J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA, 89: 4495-4499, 1992
38. Fujiwara, T , Grimm, E. A., Mukhopadhyay, T., Cai, D. W., Owen-Schaub, L B., and Roth, J. A. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res., 53: 4129-4133, 1993.
39. Fujiwara, T., Grimm, E A , Mukhopadhyay, T., Zhang, W. W., Owen-Schaub, L. B., and Roth, J. A Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res., 54: 2287-2291, 1994.
40. Liu, T. J , Zhang, W. W., Taylor, D L., Roth, J. A., Goepfert, H., and Clayman, G. L. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res., 54: 3662-3667, 1994.
41. Harbury, P. B , Zhang, T., Kim, P. S., and Alber, T A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants. Science (Washington DC), 262. 1401-1407, 1993
42. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G. Smith, J A., and Struhl, K Current Protocols in Molecular Biology. New York: Greene/Wiley Publishing Associates, 1994.
43. Waterman, J. L. F., Shenk, J. L., and Halazonetis, T. D. The dihedral symmetry of the p53 tetramerization domain mandates a conformational switch upon DNA binding. EMBO J., 14: 512-519, 1995.
44. Ellenberger, T E., Brandl, C. J., Struhl, K., and Harrison, S. C. The GCN4 basic region leucine zipper binds DNA as a dimer of uninterrupted α helices: crystal structure of the protein-DNA complex. Cell, 71: 1223-1237, 1992.
45. Zhang, K., Chaillet, J. R., Perkins, L A., Halazonetis, T. D., and Perrimon, N. Drosophila homolog of the mammalian jun oncogene is expressed during embryonic development and activates transcription in mammalian cells. Proc. Natl. Acad. Sci. USA, 87: 6281-6285, 1990.
46. Halazonetis, T D. An enhancer "core" DNA-binding and transcriptional activity is induced upon transformation of rat embryo fibroblasts. Anticancer Res., 12: 285-292, 1992.
47. Halazonetis, T. D., Davis, L. J. and Kandil, A. N Wild-type p53 adopts a "mutant"-like conformation when bound to DNA. EMBO J., 12: 1021-1028, 1993.
48. Snedecor, G. W., and Cochran, W. G. Statistical Methods, Ed. 6. Ames, IA: Iowa State University Press, 1967.
49. Schimenti, K., J., and Jacobberger, J. W Fixation of mammalian cells for flow cytometric evaluation of DNA content and nuclear immunofluorescence. Cytometry, 13: 48-59, 1992.
50. Landschulz, W. H., Johnson, P. F., and McKnight, S. L. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science (Washington DC), 240: 1759-1764, 1988.
51. Hope, I. A , and Struhl, K. GCN4, a eukaryotic transcriptional activator protein, binds as a dimer to target DNA. EMBO J., 6: 2781-2784, 1987.
52. O'Shea, E. K , Rutkowski, R., and Kim, P. S. Evidence that the leucine zipper is a coiled coil. Science (Washington DC), 243: 538-542, 1989.
53. O'Shea, E. K., Klemm, J. D , Kim, P. S., and Alber, T. X-ray structure of the GCN4 leucine zipper, a two-stranded, parallel coiled coil. Science (Washington DC), 254: 539-544, 1991.
54. Shaulsky, G., Goldfinger, N., Ben-Ze'ev, A., and Rotter, V. Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis. Mol. Cell. Biol., 10: 6565-6577, 1990.
55. Funk, W D., Pak, D. T., Karas, R. H., Wright, W. E., and Shay, J. W. A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell. Biol , 12. 2866-2871, 1992.
56. Hupp, T. R., Meek, D. W., Midgley, C. A., and Lane, D. P. Regulation of the specific DNA binding function of p53 Cell, 71: 875-886, 1992.
57. Hupp, T. R., and Lane, D P. Allosteric activation of latent p53 tetramers. Current Biol., 4: 865-875, 1994
58. Pietenpol, J. A , Tokino, T., Thiagalingam, S., El-Deiry, W. S., Kinzler, K. W., and Vogelstein, B. Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci. USA. 91: 1998-2002, 1994.
59. Chrambach, A The Practice of Quantitative Gel Electrophoresis, pp. 111-128. Weinheim, Germany, VCH Verlagsgesellschaft, 1985.
60. Hedrick, J L , and Smith, A. J. Size and charge isomer separation and estimation of molecular weights of proteins by disc gel electrophoresis. Arch Biochem. Biophys., 126: 155-164, 1968.
61. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D B., Parsons, R., Trent, J M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993
62. Hainaut, P., Hall, A , and Milner, J Analysis of p53 quaternary structure in relation to sequence-specific DNA binding. Oncogene, 9: 299-303, 1994.
63. Wu, X., Bayle, J. H., Olson, D., and Levine, A. J. The p53-mdm2 autoregulatory feedback loop. Genes & Dev, 7: 1126-1132, 1993
64. Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S , Vogelstein, B., and Fornace, A. J. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71: 587-597, 1992.
65. Miyashita, T , and Reed, J C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80: 293-299, 1995.
66. O'Shea, E. K., Lumb, K. J , and Kim, P. S. Peptide "Velcro": design of a heterodimeric coiled coil. Current Biol. 3. 658-667, 1993.
67. Chang, H., Bao, Z., Yao, Y , Tse, A. G. D., Goyarts, E. C., Madsen, M., Kawasaki, E., Brauer, P. P , Sacchettini, J C., Nathenson, S. G., and Reinherz, E. L. A general method for facilitating heterodimeric pairing between two proteins: application to expression of α and β T-cell receptor extracellular segments. Proc. Natl Acad. Sci. USA, 91: 11408-11412, 1994
68. Dittmer, D , Pati, S , Zambetti, G., Chu, S., Teresky, A. K., Moore, M., Finlay, C., and Levine, A. J Gain of function mutations in p53. Nat. Genetics, 4. 42-46, 1993.
69. Harvey, M., Vogel, H., Morris, D , Bradley, A , Bernstein, A , and Donehower, L. A A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice. Nat. Genet., 9: 305-311, 1995